The effectiveness of aspirin in preventing DVT after lumbar canal stenosis Surgeries

Evaluation of the effectiveness of aspirin in preventing DVT after lumbar spinal stenosisSurgeries

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210825052290N1

Enrollment

102

Registered

2021-12-06

Start date

2022-01-21

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Vein Thrombosis. Acute embolism and thrombosis of deep veins of lower extremity

Interventions

Intervention 1: Intervention group: Candidates for decompression stenosis surgery who will receive 325 mg oral aspirin twice daily for 3 weeks after surgery. Intervention 2: Control group: Yamaran is

Eligibility

Sex/Gender

All

Age

40 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients over 40 years of age who have undergone decompression of spinal canal stenosis Patients' informed consent

Exclusion criteria

Exclusion criteria: Prohibition of aspirin use Concomitant musculoskeletal diseases including severe osteoarthritis, rheumatoid arthritis, fibromyalgia

Design outcomes

Primary

Measure	Time frame
Frequency of DVT after lumbar spinal stenosis. Timepoint: After the intervention and 3 months after taking aspirin. Method of measurement: Intravenous color Doppler ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Habibollahzadeh

Iran University of Medical Sciences

alihabibollahzadeh.ortho@gmail.com+98 21 3354 2001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026